Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.1 USD | +6.16% | +9.15% | -54.91% |
06-20 | SAB Biotherapeutics, Inc. has Changed its Name to SAB BIO | CI |
06-07 | Brookline Capital Initiates SAB Biotherapeutics With Buy Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.91% | 28.61M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- Wall Street Set to Open Higher; Jobless Claims Rise as Producer Price Index Comes in Lower Than Expected